納菲制藥
Nasal-Phyto
Categories Of News
New drugs that benefit 340 million patients worldwide are expected to be declared for listing next y
Author：adminTime：2019/12/5 21:19:23Click：1811
Oyster Point Pharmaceuticals has submitted a NASDAQ listing application to the US Securities and Exchange Commission, and plans to raise $ 85 million in an IPO. This is a biotechnology company dedicated to developing first-in-class therapies for dry ····
The first new medicine in 20 years! UCB's new epilepsy drug Nayzilam receives FDA approval
Author：adminTime：2019/11/28 9:52:07Click：1880
Belgian pharmaceutical company UCB recently announced that the US FDA has approved its latest antiepileptic drug (AED) Nayzilam (midazolam) nasal spray CIV. This is a benzodiazepine drug for nasal administration. It is suitable for the emergency trea····
Nasal spray for recurrent seizures! Neurelis Valtoco (Diazepam Nasal Spray) Enters Formal Review in
Author：adminTime：2019/11/28 9:47:27Click：1814
September 30, 2018 / BIOON /-Biopharma, a specialist pharmaceutical company based in San Diego, USA, focuses on licensing, developing, and commercializing drugs for epilepsy and other central nervous system (CNS) diseases. Recently, the company annou····
Newly discovered nasal spray may solve the problem of patients with sudden heart disease
Author：adminTime：2019/11/28 9:32:13Click：1803
Researchers report that experimental nasal sprays can help treat common rapid heart rate disorders. A spray called Etripamil was tested in paroxysmal supraventricular tachycardia (PSVT) patients. PSVT affects approximately 500,000 Americans and resul····